Pfizer Selects ChemAxon’s Markush Platform

22 Jan 2010
Sarah Sarah
Marketing / Sales

Product news

ChemAxon has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer’s global R&D facilities.

“Markush structure search and enumeration is becoming of critical importance for structure IP and patent development.” said Alex Drijver, CEO of ChemAxon. “It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.”

Links

Tags

Chem / BioinformaticsCheminformatics and bioinformatics are computational techniques used in chemistry and biology, respectively, for data acquisition, processing and storage. Cheminformatics focuses on compound information, whereas bioinformatics is mainly applied to analysis and modeling of genomics, genetic and sequencing information. Hardware and software is available for data acquisition, analysis, management and storage.Integration ServicesIncorporate lab systems, software and equipment with integration services.Data MiningData mining is an important process for extracting information, patterns and trends from data. Data mining software, databases, reference materials and storage packages are available to process lab data.
Pfizer Selects ChemAxon’s Markush Platform